BioGaia AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 317.69 million compared to SEK 257.73 million a year ago. Net income was SEK 101.5 million compared to SEK 79.5 million a year ago. Basic earnings per share from continuing operations was SEK 1.01 compared to SEK 0.79 a year ago. Diluted earnings per share from continuing operations was SEK 1.01 compared to SEK 0.79 a year ago.
For the nine months, sales was SEK 998.73 million compared to SEK 829.67 million a year ago. Net income was SEK 297.99 million compared to SEK 234.35 million a year ago. Basic earnings per share from continuing operations was SEK 2.95 compared to SEK 2.32 a year ago. Diluted earnings per share from continuing operations was SEK 2.95 compared to SEK 2.32 a year ago.